Increased secretory leukoprotease inhibitor in patients with nonsmall cell lung carcinoma.
about
alpha1-antitrypsin and its C-terminal fragment attenuate effects of degranulated neutrophil-conditioned medium on lung cancer HCC cells, in vitroA compendium of gene expression in normal human tissues.Emerging multifunctional aspects of cellular serine proteinase inhibitors in tumor progression and tissue regeneration.Secretory leukocyte protease inhibitor promotes the tumorigenic and metastatic potential of cancer cellsBlood-based lung cancer biomarkers identified through proteomic discovery in cancer tissues, cell lines and conditioned mediumThe secretory leukocyte protease inhibitor (SLPI) suppresses cancer cell invasion but promotes blood-borne metastasis via an invasion-independent pathway.Secretory leukocyte peptidase inhibitor and lung cancer.Secretory leukocyte protease inhibitor is a survival and proliferation factor for castration-resistant prostate cancer.Characterization of epithelial-mesenchymal transition intermediate/hybrid phenotypes associated to resistance to EGFR inhibitors in non-small cell lung cancer cell lines.Secretory leukocyte protease inhibitor (SLPI) as a potential target for inhibiting metastasis of triple-negative breast cancers.Targeted gene therapy of the HSV-TK/hIL-12 fusion gene controlled by the hSLPI gene promoter of human non-small cell lung cancer in vitro.Effect of secretory leukocyte protease inhibitor on migration and invasion of human KB oral carcinoma cells
P2860
Q24792711-9E8DE0EE-69F0-4EF5-8676-64081BF08F6CQ34107680-A36EF76A-1580-4F8A-8059-E993F0B26F5BQ34592412-E1CB7489-BEBF-4064-9B41-9155EFF9C436Q35022070-A6DCA711-02BE-4B3A-9592-5919712F1FB8Q35957217-71EA48D7-55EF-4705-B281-AC17422492F6Q36190618-8C02CA7A-6EBD-474F-8FC9-CA292E54C006Q37124951-5595EBCD-1AEA-46DA-94BB-154A169F3840Q38794223-9A4D2D0F-6F0D-49B4-90CE-2A17BB4D6F7CQ47154025-E9B97FC0-4169-4A1C-96C0-3FBC68E88FD2Q47220626-0A9D6C0A-0237-4D17-8BB7-C3B1FF392E0FQ54112053-5542A59F-D6A4-4FC8-A8F9-6895A9F8012FQ58287182-487FB0BF-A8D7-423B-A60B-07321081EFB1
P2860
Increased secretory leukoprotease inhibitor in patients with nonsmall cell lung carcinoma.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh-hant
name
Increased secretory leukoprote ...... nonsmall cell lung carcinoma.
@en
Increased secretory leukoprote ...... nonsmall cell lung carcinoma.
@nl
type
label
Increased secretory leukoprote ...... nonsmall cell lung carcinoma.
@en
Increased secretory leukoprote ...... nonsmall cell lung carcinoma.
@nl
prefLabel
Increased secretory leukoprote ...... nonsmall cell lung carcinoma.
@en
Increased secretory leukoprote ...... nonsmall cell lung carcinoma.
@nl
P2093
P2860
P1433
P1476
Increased secretory leukoprote ...... nonsmall cell lung carcinoma.
@en
P2093
Ameshima S
Ishizaki T
Mitsuhashi H
Miyamori I
P2860
P304
P356
10.1002/1097-0142(20001001)89:7<1448::AID-CNCR6>3.0.CO;2-Q
P407
P577
2000-10-01T00:00:00Z